ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Arrowhead Pharmaceuticals Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
New Jersey Resources Reports Fiscal 2026 Third-Quarter Results
Danaos Corporation Reports Second Quarter and Half Year Results for the Period Ended June 30, 2026
JELD-WEN Reports Second Quarter 2026 Results and Updates Guidance
HealthStream Announces Second Quarter 2026 Results
Ryder Earns Top-10 Industry Ranking on TIME’s Inaugural America’s Best Companies List
Versant Completes Acquisition of Full Swing
JBG SMITH Postpones Release of Second Quarter 2026 Financial Results